Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease

Low Doses of Simvastatin Therapy Ameliorate Cardiac Inflammatory Remodeling in Trypanosoma cruzi-Infected Dogs

(2011) Lilian Melo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Mechanisms for the anti-inflammatory effects of statins

(2011) De-xiu Bu et al.   CURRENT OPINION IN LIPIDOLOGY

Inflammation and the Development of Atherosclerosis

(2011) Yoshiko Mizuno et al.   Journal of Atherosclerosis and Thrombosis

Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells

(2010) J. S. Coelho dos Santos et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Statins and inflammation: an update

(2010) Petter Quist-Paulsen   CURRENT OPINION IN CARDIOLOGY

Evaluation of Biological and Biochemical Quality of Whey Protein

(2010) Fabiano Kenji Haraguchi et al.   JOURNAL OF MEDICINAL FOOD

Increased type 1 chemokine expression in experimental Chagas disease correlates with cardiac pathology in Beagle dogs

(2010) Paulo M.M. Guedes et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection

(2009) Daniela M. Santos et al.   ACTA TROPICA

Plasma concentrations of tumour necrosis factor-alpha, tumour necrosis factor-related apoptosis-inducing ligand, and FasLigand/CD95L in patients with Chagas cardiomyopathy correlate with left ventricular dysfunction

(2009) Jamille Fernandes Lula et al.   EUROPEAN JOURNAL OF HEART FAILURE

Trypanosoma cruzi: Participation of cholesterol and placental alkaline phosphatase in the host cell invasion

(2009) S. Priotto et al.   EXPERIMENTAL PARASITOLOGY

CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection

(2009) Cláudia N. Paiva et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true

(2009) Joseli Lannes-Vieira et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Ergosterol biosynthesis and drug development for Chagas disease

(2009) Julio A Urbina   MEMORIAS DO INSTITUTO OSWALDO CRUZ

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI

(2009) B Zingales et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke

(2009) Xu Cui et al.   NEUROBIOLOGY OF DISEASE

Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruziactivity during acute phase of experimental Chagas disease

(2009) G. de PAULA COSTA et al.   PARASITE IMMUNOLOGY

The effect of simvastatin on the serum monocyte chemoattractant protein-1 and intracellular adhesion molecule-1 levels in diabetic rats

(2008) Yang Lin et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage

(2008) Gabriela A. Medeiros et al.   MICROBES AND INFECTION

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions

(2008) Ivo Santana Caldas et al.   PARASITOLOGY RESEARCH